Market Place
Sourcing Support
Aegerion`s Biologic Yyalipt (Metreleptin) Receives Approval in the U.S.
31 Mar 2023 //
FDA
Aegerion`s Biologic Myalept (Metreleptin) Receives Approval in the U.S.
28 Feb 2022 //
FDA
Aegerion`s Biological Metreleptin Receives Approval In US
14 Jun 2021 //
FDA
Aegerion`s Myalept ( Metreleptin) Receives Supplemental Approval in US
16 Jul 2020 //
FDA
Amryt buys Aegerion via bankruptcy, adding sales to support R&D
26 Sep 2019 //
FIERCE BIOTECH
Coming out of Chapter 11, Aegerion jumps into welcome arms of Irish pharma
25 Sep 2019 //
ENDPTS
The top 10 most-expensive meds in the U.S.—and they`re not the usual suspects
13 Jun 2019 //
FIERCE PHARMA
Amryt to expand rare disease portfolio with $311m Aegerion merger
23 May 2019 //
PHARMAPHORUM
Novelion`s Announces Subsidiary Aegerionto Recapitalize Court Supervised Process
20 May 2019 //
NASDAQ
The 20 most expensive retail drugs in 2018
29 Dec 2018 //
FIERCE PHARMA
Aegerion`s Metreleptin Receives Supplemental Approval in US
21 Dec 2018 //
FDA
U.S. judge sentences Novelion`s Aegerion in drug marketing case
01 Feb 2018 //
REUTERS
Novelion unit asks U.S. judge to approve plea deal, cites money woes
23 Dec 2017 //
REUTERS
Aegerion’s Myaleptr (Metreleptin) Receives Supplemental Approval In US
13 Dec 2017 //
FDA
Judge rejects Aegerion`s $36M Juxtapid settlement with DOJ
22 Nov 2017 //
FIERCE PHARMA
Aegerion pleads guilty to US marketing violations
26 Sep 2017 //
PHARMA TIMES
Novelion`s Aegerion resolves U.S. drug probes for $40 million
22 Sep 2017 //
REUTERS
Aegerion introduces Juxtapid in Japan for familial hypercholesterolemia
20 Dec 2016 //
PHARMABIZ
Novelion Therapeutics’ Subsidiary Launches Juxtapid in Japan
16 Dec 2016 //
GLOBENEWSWIRE
Aegerion Pharma inks licensing pact with Amryt Pharma for Lojuxta
06 Dec 2016 //
PHARMABIZ
Aegerion & QLT Complete Merger Transaction; QLT to Change Name to Novelion
29 Nov 2016 //
GLOBENEWSWIRE
Aegerion`s Juxtapid Capsules Receives Pricing Authorization in Japan
17 Nov 2016 //
GLOBENEWEWIRE
Cash-strapped Aegerion scouts for deals to recover from financial hits
20 May 2016 //
FIERCE PHARMA
Aegerion to pay $40M and plead guilty to illegally marketing cholesterol drug
13 May 2016 //
STAT
Facing Tough Competition from Regeneron & Amgen, Aegerion Slashes 25% Workforce
11 Feb 2016 //
BIOSPACE
Pursuing new deals to grow the pipeline, Szela axes staffers in Aegerion reorg
11 Feb 2016 //
FIERCE BIOTECH
Aegerion names Mary Szela CEO to replace controversial,overly talkative, Beer
08 Jan 2016 //
FIERCE PHARMA
Up and down the ladder: The latest comings and goings
06 Jan 2016 //
STAT
Common Antibiotics Cause Arrhythmias, Death And Everything Else
11 Nov 2015 //
FORBES
Ironwood (IRWD), Aegerion (AEGR), and MannKind Corporation (MNKD) Face Stiff Headwinds: Analyst
17 Aug 2015 //
BIOSPACE
Aegerion reaches a cease-fire with its activist agitators
31 Mar 2015 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.